Hepatotoxicity associated with 6-methyl mercaptopurine formation during azathioprine and 6-mercaptopurine therapy does not occur on the short-term during 6-thioguanine therapy in IBD treatment

Add time:07/16/2019    Source:sciencedirect.com

Background and aimsHigh concentrations of methylated thiopurine metabolites, such as 6-methyl mercaptopurine, are associated with hepatotoxicity during administration of the conventional thiopurines azathioprine or 6-mercaptopurine in IBD patients. Metabolization of the non-conventional thiopurine 6-thioguanine does not generate 6-methyl mercaptopurine. Hence, the aim of our study was to evaluate hepatotoxicity during 6-thioguanine in IBD patients who previously failed conventional thiopurines due to 6-methyl mercaptopurine associated hepatotoxicity.

We also recommend Trading Suppliers and Manufacturers of 9-METHYL-6-THIOPURINE (cas 1006-20-8). Pls Click Website Link as below: cas 1006-20-8 suppliers

Prev:Replicated flux measurements of 1,3-DICHLOROPROPENE (cas 1006-02-6) emissions from a bare soil under field conditions
Next:Determination of extracellular and intracellular thiopurines and methylthiopurines by high-performance liquid chromatography)